Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Temozolomide for Treatment of Malignant Gliomas
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Motexafin gadolinium (Primary) ; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions
- Sponsors Pharmacyclics
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Planned number of patients changed to 24 as reported by ClinicalTrials.gov.
- 18 Aug 2005 New trial record.